Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

US Approved Rx

27

Possibly Marketed Outside US

3

Other

2

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

27

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1921

27

1980

3

Unknown

2

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Fatigue

27

Hyperphosphatemia

27

Hypophosphatemia

27

Lose body protein

27

Nausea

27

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Diagnostic

27

Palliative

27

Primary

27

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

29

Mixture

3

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

32

CAS

31

EPA CompTox

30

PUBCHEM

29

SMS_ID

25

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

1

BLOOD AND BLOOD FORMING ORGANS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

1

LAXATIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

I.V. SOLUTION ADDITIVES

1

LAXATIVES

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Electrolyte solutions

1

Enemas

1

Osmotically acting laxatives

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Salts, Hydrates, Esters, etc.

28

Principal Form

4

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 10 of 32 results

First page disabled
Previous page disabled
1
Next page
Next page

Phosphate ion

NK08V8K8HR

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

2-THIOPHENETHIOL

F3LB1437XQ

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

O-NITROANILINE

2519U0541L

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

IODATE ION

877S7T6EXV

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 1980

Class (Stereo):

CHEMICAL (ACHIRAL)

The iodate ion is an oxoanion of iodine bearing a negative charge and containing three oxygen atoms. Because it is more stable than iodide, most health authorities preferentially recommend iodate as an additive to salt for correcting iodine deficienc...

y. In humans and rats, oral bioavailability of iodine from iodate is virtually equivalent to that from iodide. When given intravenously to rats, or when added to whole blood or tissue homogenates in vitro or to foodstuff, iodate is quantitatively reduced to iodide by nonenzymatic reactions, and thus becomes available to the body as iodide. Therefore, except perhaps for the gastrointestinal mucosa, exposure of tissues to iodate might be minimal. At much higher doses given intravenously (i.e., above 10 mg/kg), iodate is highly toxic to the retina. Ocular toxicity in humans has occurred only after exposure to doses of 600 to 1,200 mg per individual. Oral exposures of several animal species to high doses, exceeding the human intake from fortified salt by orders of magnitude, pointed to corrosive effects in the gastrointestinal tract, hemolysis, nephrotoxicity, and hepatic injury.

Phosphoric Acid

E4GA8884NN

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

AMMONIUM SODIUM PHOSPHATE TETRAHYDRATE

K78U8WLV4H

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

PHOSPHATE ION(2-)

33UE6C4909

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

AMMONIUM PHOSPHATE, TRIBASIC

2ZJF06M0I9

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

AMMONIUM SODIUM PHOSPHATE

SWP615T2VF

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

MONOBASIC POTASSIUM PHOSPHATE

4J9FJ0HL51

Export Data
Search for Structure

Status:

US Approved Rx (1981)

First marketed in 1921

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Hypophosphatemia

Sore muscles & joints

Lose body protein

Occasional sleeplessness

Hypophosphatemia

Hyperphosphatemia

Phosphate is a major intracellular anion in mammals. Hydrogen phopshate is a protonated form of phosphate. In serum, phosphate exists in two forms, dihydrogen phosphate (H2PO4) and its salt, mono-hydrogen phosphate (HPO4). At the physiologic pH of 7....

40, the pK of H2PO4 is 6.8 and the ratio of HPO4 to H2PO4 is 4:1. Altered level of phosphate can be an indicator of various disorders, such as chronic renal failure, hypoparathyroidism, familial intermittent hyperphosphatemia, endocrine disorders, hyperthyroidism, acromegaly, juvenile hypogonadism, etc. These disorders may lead to either hyper- or hypophosphatemia, which can be caused by cellular shifts of phosphate. Patients with hypophosphatemia can be treated with dietary phosphate supplements (potassium phosphate, for example).

Showing 1 - 10 of 32 results

First page disabled
Previous page disabled
1
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1